Home > Back to Publisher > Report Information

U.S. Organ Transplant Pharmaceuticals Markets

Frost & Sullivan
August 1, 2002
SKU: MC803377

Abstract Table of Contents Related Reports

Countries covered: United States

U.S. Organ Transplant Pharmaceuticals Markets

Organ Transplantation Pharmaceuticals: New Therapies, New Solutions

Impressive developments in the field of transplant immunosuppression therapies have given rise to high expectations of revolutionary solutions in the near future. New side-effect sparing chronic immunosuppressive drugs and prophylactic uses of acute immunosuppressive therapies such as monoclonal and polyclonal antibodies are making transplantation one of the most successful and promising areas of medicine.

This Frost & Sullivan research on the U.S. Organ Transplant Pharmaceuticals Markets spans the most important aspects of the solid organ transplant market - research and development (R&D) products, top competitors, demand and revenue forecasts from 1998 to 2008, challenges and opportunities, and technology trends. This study covers chronic and acute immunosuppressants markets.

Improved Survival Rates and New Patient Groups Provide Market Opportunity

Since the advent of organ transplants, survival rates of transplant recipients have improved, and, it is expected that there will be a sustained demand for improved anti-rejection pharmaceuticals. Also, a rise in organ transplants that were previously rare, such as those of the intestines, lung, and kidney-pancreas, intensify the demand for improved immunosuppressants. Adverse side-effect profiles weigh down on many of the current therapeutics providing pharmaceutical companies tremendous initiative to develop drugs that are safer and more effective.

Prospective markets lie in new patient groups such as children, pregnant women, and ethnic groups, whose immune system may require different doses/types of immunosuppression. As well, currently marketed products may opt to seek FDA approval for use in additional types of transplants. "The opportunity for expanded indications across the organ transplant field creates profit potentials for anti-rejection pharmaceuticals," says the analyst.

Prophylactic Use of Immunosuppressants Contributes to Revenues

According to the author, "In acute immunosuppression markets, there is a trend towards increasing prophylactic use of monoclonal and polyclonal antibodies." Superior efficacy and long-term improvements in organ transplant outcomes are factors that are more important than price in this market. Therefore, this market is quality-driven rather than price-driven.

With several ongoing research and development projects for both chronic and acute immunosuppressants, the market can expect the introduction of innovative products that will offer clinical solutions to some of the currently unmet market needs.

1 Executive Summary
A. Executive Summary
1 Executive Summary

2 Total Market
A. Overview
1 The Immune System and Organ Transplant Rejection
2 The History of Organ Transplant Immunosuppression
3 The Nature of the Market
4 Report Scope and Segmentation
B. Market Dynamics
1 Challenges
2 Drivers
3 Restraints
4 Market Engineering Analysis
C. Forecasts and Trends
1 Market and Technology Trends
2 Revenue Forecasts
3 Market Share Analysis
D. Strategic Recommendations
1 Strategic Recommendation 1
2 Strategic Recommendation 2
3 Strategic Recommendation 3
E. Market Engineering Awards
1 Product Line Strategy - Novartis Pharmaceutical Corporation
2 Technology Innovation - Isotechnika Inc.
3 Market Penetration - Roche Laboratories
4 Product Innovation - SangStat Medical Corporation
5 Competitive Strategy Award- Abbott Laboratories

3 Solid Organ Transplant Demand and Supply Analysis
A. Total Demand and Supply Analysis
1 Overview
B. Demand and Supply Analysis by Organ Type
1 Kidney Transplants
2 Liver Transplants
3 Heart Transplants
4 Lung Transplants
5 Pancreatic Transplants
6 Intestinal Transplants
7 Combined Organ Transplants

4 U.S. Chronic Immunosuppressant Therapies Market
A. Overview
1 Introduction
2 Market and Technology Trends
3 Market Engineering Analysis
B. Forecasts and Trends
1 Revenue Forecasts
2 Revenue Forecast Assumptions
3 Market Share Analysis
4 Demand Analysis
5 Pricing Trends
C. Competitive Analysis
1 Product Analysis - Calcineurin Inhibitors
2 Product Analysis - TOR Inhibitors
3 Product Analysis - Antimetabolites
4 Product Analysis - Corticosteroids
5 Competitive Structure
D. Emerging Technologies
1 Biotechnology Trends
2 Product Pipeline

5 U.S. Acute Immunosuppressant Therapies Market
A. Overview
1 Introduction
2 Market and Technology Trends
3 Market Engineering Analysis
B. Forecasts and Trends
1 Revenue Forecasts and Assumptions
2 Market Share Analysis
3 Demand Analysis
4 Pricing Trends
C. Competitive Analysis
1 Product Analysis - Prophylactic Agents
2 Product Analysis - Acute Rejection Episode Treatment Agents
3 Comparative Studies
4 Competitive Structure
5 Product Pipeline

More United States Prescription Drugs Reports

2012 Healthcare Business Market Research Handbook by Richard K. Miller & Associates
The 2012 Healthcare Business Market Research Handbook presents a comprehensive analysis of the $2.8 trillion U.S. healthcare marketplace with the most recent statistics and data ...

Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report by IBISWorld
Brand Name Pharmaceutical Manufacturing in the US Prescription for growth With healthcare reform allowing more individuals to gain prescription coverage, brand-name pharmaceutical and medicine manufacturers will experience ...

Analysis of the United States Contract Manufacturing Outsourcing Market by Frost & Sullivan
Contract manufacturing outsourcing (CMO) companies provide independent manufacturing services for pharmaceutical and biotechnological markets. This study covers the U.S. commercial manufacturing and packaging of pharmaceutical ...

United States Pharmaceuticals and Healthcare Report Q2 2012 by Business Monitor International
BMI View: Economics and politics are increasingly exerting an influence on the US pharmaceuticalmarket. This is in stark contrast to the late 1990s and early ...

The US Pharmaceutical Market Outlook to 2016 - Evolving Opportunities in the Biologics Segment by AM Mindpower Solutions
EXECUTIVE SUMMARY The report titled “The US Pharmaceutical Market Outlook to 2015 – Evolving Opportunities in the Biologics Segment” provides a comprehensive analysis on the Pharmaceutical ...

See all reports like this >>

More United States Reports

e-Discovery Software Publishing in the US - Industry Market Research Report by IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...

D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report United States January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Coal - US - a snapshot (2010) by Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...

See all reports like this >>

U.S. Organ Transplant Pharmaceuticals Markets

Share this report

Other tasks

Research Assistance

Related Markets

Prescription Drugs Reports

Free Alert Me service